From: The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors
Type of cancer
Heterozygous patients (%)
Patients with LOH (%)
HER2-positive
33/85 (39)
16/33 (48)
HER2-negative
22/52 (42)
2/22 (9)
Cervical cancer
26/65 (40)
11/26 (42)
Lung cancer (ā)
6/18 (33)
4/6 (67)